Gastrointestinal withdrawal impacts: 🥣 Nutrition | 📈 Growth | 🧠 Brain | 💞 Bonding | 🫂 Outcomes Join Dr. Forbes at #AWHONN2025 to explore nutrition & person-centered care for OEI.

Cracking the code to successful feeding in OEI starts with the right tools: 🍼 Nutrition strategies 🎶 Music & regulation techniques 👩‍👧 Engaged, supported parents We’re bringing all of this to AWHONN 2025. Will you be there? Let’s connect: nascend.com/learn-more

<20% of moms w/ OUD provide breastmilk despite its power to ease withdrawal & support bonding. What’s getting in the way? Join us at #AWHONN 2025 for Nourishing Bonds w/ Dr. Forbes + Dixie Weber to explore how we can do better. 🔗 nascend.com/learn-more #AWHONN2025

Myth! 🔎 Studies indicate that prenatal marijuana exposure is associated with reduced attention skills, with effects appearing to be more significant in girls compared to boys.

Medicaid is the nation’s leading payer of care for newborns with neonatal opioid withdrawal syndrome (NOWS). Any changes to how that care is supported could impact access to treatment for these infants.

Free CE webinar for healthcare & public health professionals. Hosted by Foundation for a Healthy KY | Featuring Dr. Dawn Forbes, NASCEND 🎓 1.5 CE credits 🔗 Register: healthy-ky.org/events/health-…

Each testing method has its own limitations. Urine reflects recent exposure, while meconium and cord tissue can capture longer-term exposure during pregnancy. Understanding the differences helps providers choose the right approach for accurate assessment and timely care.

Dr. Forbes attended the 2025 Mead Johnson Global Nutrition Summit & Live Speaker Training last week in Salt Lake City. The event highlighted nutrition research, AI in healthcare & strategies to elevate expert presentations , plus celebrated 120 years of MJN!

With 20–40% of opioid-exposed infants going home undiagnosed, it’s time to ask: why is this happening, and how can we do better? Stay tuned as we unpack the reasons behind this and what it means for babies and families.

Fact: Many opioid-exposed infants experience withdrawal. Symptoms depend on timing + exposure. Knowing the mother’s last exposure helps anticipate when symptoms may appear. What signs of withdrawal do you see most often in your setting?

Standard NOWS scoring uses 21 subjective symptoms, but Forbes AssessPro focuses on 6 evidence-based symptoms that truly indicate withdrawal. This helps providers give consistent care, reduce unnecessary treatment, and improve outcomes for opioid-exposed infants.

🎧 Worth the Listen: Our friends at Generation-O join The Uplift Appalachia Podcast to discuss the importance of visibility, advocacy, and compassion for children with substance exposure. Listen now: rss.com/podcasts/intri…

We are devastated by the tragic plane crash in our community on November 4, 2025. Our hearts are with all those affected during this unimaginable time, and we extend our deepest gratitude to the first responders who rushed to help.

The best comfort care is family engagement. When we engage early, standard comfort measures become more effective, helping to reduce the number of hospital days and the need for pharmacological treatment in OEI.

Fact! Infants experiencing withdrawal from heroin exposure often have severe gastrointestinal (GI) symptoms, which can lead to dehydration and electrolyte imbalances.

Grateful to attend the 5th Canopy Good Business Summit! 🌿 We are excited to carry this momentum of JOY into 2026.

We’re excited that our Founder and CEO, K. Dawn Forbes, MD, will present at Nemours Hot Topics 2025. She’ll share new findings on how digital tools reduce treatment duration, medication exposure and days in the hospital for opioid-exposed infants. Hope to see you there.

How much can digital health improve Neonatal Opioid Withdrawl Syndrome (NOWS) care? We're seeing meaningful progress as we expand our digital assessment tools to support more consistent decisions for infants and families. We'll share our latest findings at Hot Topics in Neonatology 2025.

NASCEND is presenting new Neonatal Opioid Withdrawl Syndrome (NOWS) research at Nemours Hot Topics in Neonatology 2025. Our digital tools are improving consistency and outcomes for opioid-exposed infants and families. More to come.

“Presenting our AssessPro data was a powerful reminder of why this work matters and how deeply the neonatal community cares about improving OEI outcomes.” Thank you for joining Hot Topics in Neonatology. CEO, K. Dawn Forbes, MD presented new Forbes AssessPro findings. Visit us at booth 18.